These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11769072)

  • 21. [International Consensus Panel--treatment strategies for superficial bladder cancer].
    Adler S; St Niclas M
    Aktuelle Urol; 2006 Sep; 37(5):320-3; discussion 322-3. PubMed ID: 17004179
    [No Abstract]   [Full Text] [Related]  

  • 22. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract.
    Chung SD
    BJU Int; 2008 Aug; 102(4):518; author reply 518-9. PubMed ID: 18699961
    [No Abstract]   [Full Text] [Related]  

  • 23. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
    Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
    J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
    Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D
    Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis of superficial bladder tumors].
    Gattegno B; Chopin D
    Prog Urol; 2001 Nov; 11(5):993-1019. PubMed ID: 11769088
    [No Abstract]   [Full Text] [Related]  

  • 27. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current world literature. Bladder cancer.
    Curr Opin Urol; 2007 Sep; 17(5):378-80. PubMed ID: 17910129
    [No Abstract]   [Full Text] [Related]  

  • 29. [Intestinal obstruction and peritoneal carcinomatosis after endoscopic resection of transitional carcinoma of urinary bladder].
    Acea Nebril B; Aguirrezabalaga González J; Fraguela Mariña F; Taboada Filgueira L; Freire Rodríguez D; Gómez Freijoso C
    Actas Urol Esp; 1997; 21(7):705-7. PubMed ID: 9412216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metachronous primary urothelial carcinoma following small cell carcinoma of the urinary bladder.
    Yao HH; Chu K; Hallot C; Lewin J
    ANZ J Surg; 2017 Jan; 87(1-2):96-98. PubMed ID: 25182753
    [No Abstract]   [Full Text] [Related]  

  • 31. Fluorescence cystoscopy.
    Vallancien G; Richard F; Haertig A; Mathieu F; Kuss R
    Prog Clin Biol Res; 1984; 162A():327-30. PubMed ID: 6483915
    [No Abstract]   [Full Text] [Related]  

  • 32. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.
    Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J
    BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Secondary appearance of a carcinoma in an excluded native bladder: Report of three cases].
    Rouache L; Cherif M; Tanneau Y; Gobet F; Pfister C
    Prog Urol; 2006 Nov; 16(5):603-6. PubMed ID: 17175961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suprapubic ultrasonography in the follow-up of superficial bladder tumors.
    Boccon-Gibod L; le Portz B; Godefroy D; Steg A
    Eur Urol; 1985; 11(5):317-9. PubMed ID: 3908114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can transabdominal ultrasonography of the bladder replace cystoscopy in the followup of superficial bladder tumors?
    Vallancien G; Veillon B; Charton M; Brisset JM
    J Urol; 1986 Jul; 136(1):32-4. PubMed ID: 3520026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of hematoporphyrin derivative (HpD) in the localization and treatment of transitional cell carcinoma (TCC) of the bladder.
    Benson RC
    Prog Clin Biol Res; 1984; 170():795-804. PubMed ID: 6241716
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of patients with upper urinary tract transitional cell carcinoma.
    Raman JD; Scherr DS
    Nat Clin Pract Urol; 2007 Aug; 4(8):432-43. PubMed ID: 17673914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
    Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
    J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transitional cell carcinoma of the bladder in first decade of life.
    Patel R; Tery T; Ninan GK
    Pediatr Surg Int; 2008 Nov; 24(11):1265-8. PubMed ID: 18813937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.